5.1 DSM-5-TR Substance Use Disorders Criteria

5.1 DSM-5-TR Substance Use Disorders Criteria

The Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, Text Revision (DSM-5-TR), published by the American Psychiatric Association (APA), provides the standardized diagnostic framework utilized by addiction counselors, psychiatrists, and clinical healthcare professionals across North America. For candidates preparing for the NAADAC National Certified Addiction Counselor Level I (NCAC I) examination, mastering the DSM-5-TR diagnostic criteria for Substance Use Disorders (SUD) is a fundamental prerequisite. A thorough understanding of how substance use is evaluated, categorized, and graded for severity is essential for accurate clinical assessment, treatment planning, level-of-care placement, and interprofessional communication.

Diagnostic Shift: From DSM-IV to DSM-5-TR

To appreciate the current diagnostic architecture, clinicians must understand the major conceptual paradigm shift that occurred when transitioning from DSM-IV-TR to DSM-5. Under DSM-IV-TR, substance-related pathology was split into two distinct, hierarchical diagnostic categories: Substance Abuse (a milder, behavioral diagnosis) and Substance Dependence (a more severe diagnosis characterized primarily by physiological dependence, tolerance, and withdrawal).

DSM-5 eliminated this categorical division in favor of a single, unified continuum termed Substance Use Disorder (SUD). Research demonstrated that the old division created clinical confusion, as individuals could meet criteria for severe dependence without meeting criteria for abuse, or experience significant life disruption without meeting physiological dependence criteria. Furthermore, DSM-5 made two critical structural adjustments to the criteria list:

1. Removal of Legal Problems: The DSM-IV criterion regarding recurrent substance-related legal problems was removed due to cultural, racial, and socio-economic biases in law enforcement and judicial practices.
2. Addition of Craving: A new criterion—craving, or a strong desire or urge to use the substance—was added, reflecting neurobiological advances demonstrating that craving represents a core symptom of addiction linked to conditioned neural circuitry in the brain's reward system.

Substance Use Disorders are diagnosed for ten distinct substance classes: Alcohol, Caffeine (which has intoxication and withdrawal but not an SUD diagnosis), Cannabis, Hallucinogens (PCP and others), Inhalants, Opioids, Sedatives/Hypnotics/Anxiolytics, Stimulants (amphetamines, cocaine), Tobacco, and Other/Unknown substances.

---

The 11 Diagnostic Criteria Across 4 Domains

The DSM-5-TR defines a Substance Use Disorder as a problematic pattern of substance use leading to clinically significant impairment or distress, manifested by meeting at least two (2) of eleven specific diagnostic criteria within a 12-month period. These 11 criteria are organized logically into four overarching clinical categories:

Category I: Impaired Control (Criteria 1–4)

These criteria assess the individual's inability to regulate, restrict, or cease their consumption of the substance.

• Criterion 1: Larger Amounts or Longer Duration: The substance is often taken in larger amounts or over a longer period than was originally intended by the individual.
• Criterion 2: Persistent Desire or Unsuccessful Cut-Down Efforts: There is a persistent desire or repeated unsuccessful efforts to cut down, reduce, or control substance use.
• Criterion 3: Excessive Time Spent: A great deal of time is spent in activities necessary to obtain the substance (e.g., visiting multiple doctors, driving long distances), use the substance, or recover from its pharmacological effects.
• Criterion 4: Craving: Craving, manifested by an intense, conscious urge or desire to use the substance. Craving is often triggered by environmental cues, emotional distress, or drug-associated stimuli.

Category II: Social Impairment (Criteria 5–7)

These criteria evaluate the downstream negative consequences of substance use on interpersonal, occupational, and social roles.

• Criterion 5: Failure to Fulfill Major Role Obligations: Recurrent substance use resulting in a failure to fulfill major role obligations at work, school, or home (e.g., repeated absences, poor work performance, suspensions from school, child neglect).
• Criterion 6: Continued Use Despite Social/Interpersonal Problems: Continued substance use despite having persistent or recurrent social or interpersonal problems caused or exacerbated by the effects of the substance (e.g., marital arguments, physical fights, estrangement from family).
• Criterion 7: Social, Occupational, or Recreational Activities Given Up: Important social, occupational, or recreational activities are given up or significantly reduced because of substance use (e.g., relinquishing hobbies, isolation from non-using friends, neglecting family events).

Category III: Risky Use (Criteria 8–9)

These criteria focus on the continued consumption of substances in settings or circumstances that pose physical or psychological danger.

• Criterion 8: Recurrent Use in Physically Hazardous Situations: Recurrent substance use in situations in which it is physically hazardous to self or others (e.g., driving an automobile, operating heavy machinery, swimming, or engaging in unsafe behaviors while intoxicated).
• Criterion 9: Continued Use Despite Physical or Psychological Knowledge: Substance use is continued despite knowledge of having a persistent or recurrent physical or psychological problem that is likely to have been caused or exacerbated by the substance (e.g., continued drinking despite alcoholic liver disease or ulcer, continued cocaine use despite severe depression or cardiac arrhythmia).

Category IV: Pharmacological Criteria (Criteria 10–11)

These criteria reflect the physiological adaptations of the central nervous system to chronic neurochemical exposure.

• Criterion 10: Tolerance: Defined by either (a) a need for markedly increased amounts of the substance to achieve intoxication or desired effect, or (b) a markedly diminished effect with continued use of the same amount of the substance.
• Criterion 11: Withdrawal: Manifested by either (a) the characteristic withdrawal syndrome for the specific substance class, or (b) taking the substance (or a closely related substance, such as a benzodiazepine for alcohol) to relieve or avoid withdrawal symptoms.

CRITICAL EXAM CAVEAT: Criteria 10 (Tolerance) and 11 (Withdrawal) are NOT counted toward an SUD diagnosis for individuals who are taking medication under appropriate medical supervision (e.g., patients taking prescribed opioid analgesics for cancer pain or prescribed benzodiazepines for chronic anxiety). Physiological adaptation is a normal biological response to prescribed medications and does not, by itself, constitute an addiction disorder.

---

Severity Grading Scale

The DSM-5-TR utilizes a continuous severity grading model based on the total number of diagnostic criteria met within the preceding 12 months:

On the NCAC I exam, questions frequently test your ability to calculate severity based on a clinical vignette listing specific client behaviors. For example, if a client reports spending excessive time acquiring cocaine (Criterion 3), experiencing intense cravings (Criterion 4), neglecting work responsibilities (Criterion 5), and continuing use despite severe anxiety (Criterion 9), the counselor must identify four criteria met, corresponding to a Moderate Cocaine Use Disorder.

---

Course and Remission Specifications

In addition to severity, counselors must assign appropriate course specifiers to describe the client's current recovery trajectory. Remission specifiers apply only after a client previously met full criteria for an SUD.

Early Remission

The specifier Early Remission is used when an individual who previously met full SUD criteria has met zero (0) criteria for at least 3 months but less than 12 months. The single exception to this rule is Criterion 4 (Craving); an individual can experience craving and still be classified as being in Early Remission, provided no other criteria are present.

Sustained Remission

The specifier Sustained Remission is applied when the individual has met zero (0) criteria (with the sole potential exception of Craving) for a continuous period of 12 months or longer.

Additional Clinical Specifiers

• On Maintenance Therapy: Used if the individual is currently taking a prescribed agonist, partial-agonist, or antagonist medication as part of Medication-Assisted Treatment (MAT)—such as methadone, buprenorphine, naltrexone, or nicotine replacement therapy—and no criteria for that substance class are met (other than tolerance or withdrawal to the maintenance agent).
• In a Controlled Environment: Used if the individual is residing in an environment where access to alcohol and drugs is strictly restricted, such as a locked inpatient psychiatric unit, a residential therapeutic community, a substance-free detention facility, or a prison, and no criteria are met.

Understanding these criteria and specifiers allows addiction counselors to formulate accurate diagnostic impressions, complete standardized billing documents, and design individual treatment plans tailored to the exact severity and stage of recovery of each client.